120 related articles for article (PubMed ID: 24184959)
1. Determining the concentrations of the squamous cell carcinoma antigen using the Maglumi 2000 automatic analyzer.
Ni X; Qi S
Minerva Med; 2014 Feb; 105(1):57-61. PubMed ID: 24184959
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma.
Chen H; Tian L; Chen J; Sun P; Han R; Wu X; Dai S
Cancer Control; 2020; 27(1):1073274820983025. PubMed ID: 33356502
[TBL] [Abstract][Full Text] [Related]
3. A rapid and sensitive chemiluminescence immunoassay based on magnetic particles for squamous cell carcinoma antigen in human serum.
Zhang H; Qi S
Clin Chim Acta; 2011 Aug; 412(17-18):1572-7. PubMed ID: 21600892
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma antigen production in nasal inverted papilloma.
Suzuki M; Deng Z; Hasegawa M; Uehara T; Kiyuna A; Maeda H
Am J Rhinol Allergy; 2012; 26(5):365-70. PubMed ID: 23168150
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma.
Bolger BS; Dabbas M; Lopes A; Monaghan JM
Gynecol Oncol; 1997 May; 65(2):309-13. PubMed ID: 9159343
[TBL] [Abstract][Full Text] [Related]
6. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
[TBL] [Abstract][Full Text] [Related]
7. Impact of anti-squamous cell carcinoma antigen antibodies on serum squamous cell carcinoma antigen levels measured by chemiluminescent immunoassay and chemiluminescent enzyme immunoassay.
Oyabu C; Sato I; Yamamoto M; Imanishi T; Sendo S; Yano Y
Lab Med; 2024 May; 55(3):341-346. PubMed ID: 37706549
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis.
Ohta S; Shibata R; Nakao Y; Azuma Y; Taniguchi K; Arima K; Suzuki S; Shiraishi H; Iwasaka T; Izuhara K
Ann Clin Biochem; 2012 May; 49(Pt 3):277-84. PubMed ID: 22402915
[TBL] [Abstract][Full Text] [Related]
9. Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma.
Chen CH; Tsai TL; Yang YS; Tsai CC
J Oral Pathol Med; 2007 Feb; 36(2):83-7. PubMed ID: 17238969
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.
Sheng X; Du X; Zhang X; Li D; Lu C; Li Q; Ma Z; Song Q; Wang C
Croat Med J; 2009 Oct; 50(5):455-64. PubMed ID: 19839069
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
Luan XM; Zhang Y; Wang SZ; Wang N; Li W; Zhang Q; Wei H; Zhang SL
Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1330-3. PubMed ID: 22883121
[TBL] [Abstract][Full Text] [Related]
13. [Squamous cell carcinoma antigen].
Nawata S; Sugino N; Kato H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():684-6. PubMed ID: 16149611
[No Abstract] [Full Text] [Related]
14. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
[TBL] [Abstract][Full Text] [Related]
15. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
Feng XY; Li JH; Li JZ; Han ZX; Xing RD
Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).
Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F
J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038
[TBL] [Abstract][Full Text] [Related]
17. Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma.
Hashimoto K; Yonemori K; Katsumata N; Hirakawa A; Hirata T; Yamamoto H; Shimizu C; Tamura K; Ando M; Fujiwara Y
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):394-8. PubMed ID: 21831511
[TBL] [Abstract][Full Text] [Related]
18. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity of recombinant squamous cell carcinoma antigen and leupin/SCCA-2: implications for tumor marker detection.
Barnes RC; Coulter J; Worrall DM
Gynecol Oncol; 2000 Jul; 78(1):62-6. PubMed ID: 10873412
[TBL] [Abstract][Full Text] [Related]
20. Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum.
Patel JL; Erickson JA; Roberts WL; Grenache DG
Clin Biochem; 2010 Dec; 43(18):1449-52. PubMed ID: 20875814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
